Your browser doesn't support javascript.
loading
In vivo analysis of aggregation propensity of low levels of mislocalized TDP-43 on cytopathological and behavioral phenotype of ALS/FTLD.
Wada, Hideki; Hikiami, Ryota; Kusui, Makiko; Minamiyama, Sumio; Asada-Utsugi, Megumi; Shodai, Akemi; Muramatsu, Shin-Ichi; Morimura, Toshifumi; Urushitani, Makoto.
Afiliação
  • Wada H; Department of Neurology, Shiga University of Medical Science, Japan; Molecular Neuroscience Research Center, Shiga University of Medical Science, Japan.
  • Hikiami R; Department of Therapeutics for Protein Misfolding Diseases, Shiga University of Medical Science, Japan. Electronic address: hikiami@belle.shiga-med.ac.jp.
  • Kusui M; Department of Neurology, Shiga University of Medical Science, Japan.
  • Minamiyama S; Department of Neurology, Shiga University of Medical Science, Japan; Department of Neurology, Kyoto City Hospital, Japan.
  • Asada-Utsugi M; Molecular Neuroscience Research Center, Shiga University of Medical Science, Japan.
  • Shodai A; Department of Neurology, Shiga University of Medical Science, Japan.
  • Muramatsu SI; Division of Neurological Gene Therapy, Center for Open Innovation, Jichi Medical University, Japan.
  • Morimura T; Research Center for Animal Life Science, Shiga University of Medical Science, Japan.
  • Urushitani M; Department of Neurology, Shiga University of Medical Science, Japan; Molecular Neuroscience Research Center, Shiga University of Medical Science, Japan; Department of Therapeutics for Protein Misfolding Diseases, Shiga University of Medical Science, Japan. Electronic address: uru@belle.shiga-med.ac.
Neurosci Res ; 193: 41-51, 2023 Aug.
Article em En | MEDLINE | ID: mdl-36804599
ABSTRACT
Mislocalization and aggregate formation of TAR DNA-biding protein of 43kD (TDP-43) in the cytoplasm are signatures of amyotrophic lateral sclerosis(ALS) and frontotemporal lobar degeneration (FTLD). However, the role of two cytopathologies in ALS/FTLD pathogenesis is unclear. This study aims to elucidate the difference in their causality of TDP-43 in ALS/FTLD in vivo, using transgenic mice expressing human TDP-43 with defective nuclear localizing signals in neurons (Cyto-TDP) and those with aggregation propensity (Cyto-aggTDP). The expression levels of both proteins are less than half of endogenous TDP-43. Despite the low amount of Cyto-aggTDP, the TDP-43 phosphorylation is more evident than Cyto-TDP. Histopathological study showed accelerated astrogliosis in the anterior cerebral cortex of both mice. Cyto-aggTDP mice demonstrated significant but faint loss of neurons in the perirhinal(PERI) and ectorhinal(ECT) areas and higher Iba1-staining in the spinal cord than aged control. Despite the lack of locomotor dysfunctions in both mice, the open-field test showed enhanced exploratory behavior, indicating that the perpetual mislocalization of TDP-43 may suffice to trigger FTLD behavior. Besides, the aggregation propensity of TDP-43 promotes phosphorylation, but its role in the clinicopathological phenotype may not be primary.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Degeneração Lobar Frontotemporal / Esclerose Lateral Amiotrófica Limite: Animals / Humans Idioma: En Revista: Neurosci Res Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Degeneração Lobar Frontotemporal / Esclerose Lateral Amiotrófica Limite: Animals / Humans Idioma: En Revista: Neurosci Res Ano de publicação: 2023 Tipo de documento: Article